Back to Search
DONALD GOFF, MD
MD
Psychiatry Physician
NPI: 1881672590Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
49431(MA)263851(NY)
Clinical Trials (9)
9
Linked Trials
0
Recruiting
6
With Results
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
NCT01981759COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
DECIFER: Depression and Citalopram In First Episode Recovery
NCT01041274COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Folate Supplementation in Schizophrenia
NCT00249288COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
NCT00742079COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
NCT00611806COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
NCT00455702COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Risperidone Augmentation in Patients With Schizophrenia
NCT00289861COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
NCT00455715COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia
NCT00573417COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia.
PMID 23467813·JAMA Psychiatry·2013
4-observational
Folate supplementation in schizophrenia: a possible role for MTHFR genotype.
PMID 21334854·Schizophr Res·2011
2-rct
D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.
PMID 21723096·Schizophr Res·2011
2-rct
A placebo-controlled study of sildenafil effects on cognition in schizophrenia.
PMID 18716761·Psychopharmacology (Berl)·2009
2-rct
Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.
PMID 19689921·J Clin Psychiatry·2009
4-observational
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.
PMID 18799288·Schizophr Res·2008
4-observational
Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.
PMID 17321111·Schizophr Res·2007
2-rct
Selective emotional processing deficits to social vignettes in schizophrenia: an ERP study.
PMID 19564165·Schizophr Bull·2011
8-other
Dysfunction of a cortical midline network during emotional appraisals in schizophrenia.
PMID 19605517·Schizophr Bull·2011
8-other
Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages.
PMID 19665729·J Psychiatr Res·2010
8-other
Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis.
PMID 19628357·J Vasc Surg·2009
4-observational
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.
PMID 19625881·J Psychiatr Pract·2009
8-other
Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.
PMID 19512978·J Clin Psychopharmacol·2009
2-rct
Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.
PMID 19476583·Prev Cardiol·2009
4-observational
Neurocognitive abnormalities during comprehension of real-world goal-directed behaviors in schizophrenia.
PMID 19413402·J Abnorm Psychol·2009
8-other
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.
PMID 19597068·Arch Intern Med·2009
4-observational
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
PMID 19640511·Biol Psychiatry·2009
3-trial
The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis.
PMID 19549732·Diabetes Care·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 PARK AVE RM 8-212
NEW YORK, NY 10016 - Phone
- (646) 754-4843
Quick Facts
- NPI
- 1881672590
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile